JD Esq - Reunion Neuroscience CEO Pres

REUNDelisted Stock  USD 1.12  0.01  0.90%   

Insider

JD Esq is CEO Pres of Reunion Neuroscience
Age 54
Webhttps://www.fieldtriphealth.com

Reunion Neuroscience Management Efficiency

The company has return on total asset (ROA) of (0.2651) % which means that it has lost $0.2651 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.8635) %, meaning that it created substantial loss on money invested by shareholders. Reunion Neuroscience's management efficiency ratios could be used to measure how well Reunion Neuroscience manages its routine affairs as well as how well it operates its assets and liabilities.
Reunion Neuroscience currently holds 3.37 M in liabilities. Reunion Neuroscience has a current ratio of 46.79, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Reunion Neuroscience's use of debt, we should always consider it together with its cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Clive BrownOxford Nanopore Technologies
N/A
Sara LeOxford Nanopore Technologies
N/A
Pr BayleyOxford Nanopore Technologies
N/A
Ruud OutersterpPharming Group NV
59
Gordon SangheraOxford Nanopore Technologies
N/A
MBA MDPharming Group NV
63
Sarah LapworthOxford Nanopore Technologies
N/A
Rajkumar PatilOKYO Pharma Ltd
65
Jeff FenstererAccustem Sciences
44
Rhodri DaviesOxford Nanopore Technologies
N/A
Deborah KnobelmanSenti Biosciences
50
Wilson WongSenti Biosciences
N/A
Mireille MScPharming Group NV
55
Susan KahlertSenti Biosciences
N/A
Gary JacobOKYO Pharma Ltd
77
Philip LeeSenti Biosciences
42
Wendy BlosserAccustem Sciences
57
Joe FlanaganAccustem Sciences
49
Stephen ToorPharming Group NV
52
Craig EsqCingulate
51
Tim CowperOxford Nanopore Technologies
N/A
Field Trip Health Ltd. engages in the development and delivery of psychedelic- assisted therapies in North America. Field Trip Health Ltd. was founded in 2008 and is headquartered in Toronto, Canada. Reunion Neuroscience operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 194 people. Reunion Neuroscience (REUN) is traded on NASDAQ Exchange in USA and employs 16 people.

Management Performance

Reunion Neuroscience Leadership Team

Elected by the shareholders, the Reunion Neuroscience's board of directors comprises two types of representatives: Reunion Neuroscience inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Reunion. The board's role is to monitor Reunion Neuroscience's management team and ensure that shareholders' interests are well served. Reunion Neuroscience's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Reunion Neuroscience's outside directors are responsible for providing unbiased perspectives on the board's policies.
MD MBA, VP Director
Nathan BSc, Chief Officer
Stephan Cote, Head Quality
Hannan Fleiman, CoFounder Director
Mujeeb Jafferi, COFounder COO
Edward CPA, Chief Officer
Vicki Reed, Chief Officer
Curtis Weber, Gen Sec
JD Esq, CEO Pres
Matt Emmer, Director Devel

Reunion Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Reunion Neuroscience a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with Reunion Neuroscience

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Reunion Neuroscience position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Reunion Neuroscience will appreciate offsetting losses from the drop in the long position's value.

Moving against Reunion Stock

  0.89CMXHF CSL LimitedPairCorr
  0.88CSLLY CSLPairCorr
  0.87REGN Regeneron PharmaceuticalsPairCorr
  0.72NVO Novo Nordisk ASPairCorr
  0.71NONOF Novo Nordisk ASPairCorr
The ability to find closely correlated positions to Reunion Neuroscience could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Reunion Neuroscience when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Reunion Neuroscience - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Reunion Neuroscience to buy it.
The correlation of Reunion Neuroscience is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Reunion Neuroscience moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Reunion Neuroscience moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Reunion Neuroscience can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.
You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Other Consideration for investing in Reunion Stock

If you are still planning to invest in Reunion Neuroscience check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Reunion Neuroscience's history and understand the potential risks before investing.
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Equity Valuation
Check real value of public entities based on technical and fundamental data
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years